Bone mineral density as a surrogate endpoint in osteoporosis trials. // The Lancet Diabetes & Endocrinology. – URL: https://www.sciencedirect.com/science/article/pii/S2213858726002469?dgcid=rss_sd_all
Bone mineral density as a surrogate endpoint in osteoporosis trials. The Lancet Diabetes & Endocrinology. https://www.sciencedirect.com/science/article/pii/S2213858726002469?dgcid=rss_sd_all
“Bone mineral density as a surrogate endpoint in osteoporosis trials.” The Lancet Diabetes & Endocrinology.
@article{article68461,
title = {Bone mineral density as a surrogate endpoint in osteoporosis trials},
journal = {The Lancet Diabetes \& Endocrinology},
url = {https://www.sciencedirect.com/science/article/pii/S2213858726002469?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...